Finance

Lists
Why is ADCT up ၁၁.၈၁%?
Dive Deeper
ADCT:NYSE
ADC Therapeutics SA
၁.၄၂ US$
+၁၁.၈၁%
(+၀.၁၅) 1D
၁.၄၁ US$
-၀.၇၀% (-၀.၀၁၀၀)
After hours
Closed: အောက် ၇, GMT-၄ ၁၆:၀၀:၀၆  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ADCT...
Open
၁.၂၅ US$
High
၁.၄၄ US$
Low
၁.၂၄ US$
Mkt. cap
၁၈.၁၃ ကုဋေ
Avg. vol.
၁.၅၉ သန်း
Volume
၁.၇၅ သန်း
52-wk high
၄.၉၈ US$
52-wk low
၀.၇၈ US$
EPS
-၀.၇၃ US$
Beta
၁.၈၆
Shares outstanding
၁၂.၇၇ ကုဋေ
No. of employees
၁၉၁
Open
၁.၂၅ US$
High
၁.၄၄ US$
Low
၁.၂၄ US$
Mkt. cap
၁၈.၁၃ ကုဋေ
Avg. vol.
၁.၅၉ သန်း
Volume
၁.၇၅ သန်း
52-wk high
၄.၉၈ US$
52-wk low
၀.၇၈ US$
EPS
-၀.၇၃ US$
Beta
၁.၈၆
Shares outstanding
၁၂.၇၇ ကုဋေ
No. of employees
၁၉၁
News stories
From web sources and news partners
https://www.dars.gov.et/
https://www.dars.gov.et/
·
ပြီးခဲ့သည့် ၂ ရက်
ADCT Q2 2026 Earnings: Narrower-Than-Expected Loss Drives Modest Stock Gain - Revenue Inflection Point
About ADC Therapeutics SA
CEO-
Employees၁၉၁
Founded၂၀၁၁
Headquarters-
Sector-
Analyst ratings
Based on 2 analysts giving stock ratings to ADCT in the past 3 months
Buy
Buy
1
Hold
1
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for ADCT in the last 3 months.
Highest
Current ၁.၄၂ US$
၅.၀၀ US$ (+၂၅၂.၁၁%)
Average
၃.၅၀ US$ (+၁၄၆.၄၈%)
Lowest
၂.၀၀ US$ (+၄၀.၈၅%)
Analyst
Recommendation
Action
Price target
Projected
Date
Leonid Timashev
RBC Capital
Hold
Maintained
၂.၀၀ US$
+၄၀.၈%
08/13/2026
Michael Schmidt
Guggenheim
Buy
Reiterated
၅.၀၀ US$
+၂၅၂.၁%
08/14/2026
Robert Burns
H.C. Wainwright
Hold
Downgraded
-
-
06/08/2026
Sudan Loganathan
Stephens
Buy
Reiterated
၅.၀၀ US$
+၂၅၂.၁%
06/04/2026
Last report
၂၀၂၆ ဩ ၁၃
Fiscal period
Q2 2026
EPS / Est. (USD)
- / -
Revenue / Est. (USD)
၁.၉၂ ကုဋေ / ၁.၈၉ ကုဋေ
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
၁.၆၄ ကုဋေ
၂.၃၁ ကုဋေ
၂.၀၉ ကုဋေ
၁.၉၂ ကုဋေ
Cost of goods sold
၂.၈၀ ကုဋေ
၁.၇၆ ကုဋေ
၂.၃၅ ကုဋေ
၁.၉၇ ကုဋေ
Cost of revenue
၂.၈၀ ကုဋေ
၁.၇၆ ကုဋေ
၂.၃၅ ကုဋေ
၁.၉၇ ကုဋေ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၁.၉၀ ကုဋေ
၂.၁၄ ကုဋေ
၂.၂၆ ကုဋေ
၂.၂၃ ကုဋေ
Operating expense
၁.၉၀ ကုဋေ
၂.၁၄ ကုဋေ
၂.၂၆ ကုဋေ
၂.၂၃ ကုဋေ
Total operating expenses
၄.၇၀ ကုဋေ
၃.၉၀ ကုဋေ
၄.၆၁ ကုဋေ
၄.၂၀ ကုဋေ
Operating income
-၃.၀၆ ကုဋေ
-၁.၆၀ ကုဋေ
-၂.၅၂ ကုဋေ
-၂.၂၇ ကုဋေ
Other non operating income
၅.၈၇ သိန်း
၂.၁၈ ကုဋေ
၂.၃၀ သန်း
၂.၀၇ ကုဋေ
EBT including unusual items
-၄.၁၀ ကုဋေ
-၆.၈၁ သန်း
-၃.၃၀ ကုဋေ
-၁.၆၆ ကုဋေ
EBT excluding unusual items
-၄.၀၆ ကုဋေ
-၄.၈၈ သန်း
-၃.၃၀ ကုဋေ
-၁.၃၉ ကုဋေ
Income tax expense
-
-၄.၀၄ သိန်း
-
-
Effective tax rate
-
၅.၉၃%
-
-
Other operating expenses
-
-
-
-
Net income
-၄.၁၀ ကုဋေ
-၆.၄၁ သန်း
-၃.၃၀ ကုဋေ
-၁.၆၆ ကုဋေ
Net profit margin
-၂၄၉.၃၈%
-၂၇.၈၀%
-၁၅၈.၁၁%
-၈၆.၀၆%
Earnings per share
-
-
-
-
Interest and investment income
၂.၄၇ သန်း
၂.၃၅ သန်း
၁.၉၉ သန်း
၁.၈၂ သန်း
Interest expense
-၁.၃၄ ကုဋေ
-၁.၃၀ ကုဋေ
-၁.၂၃ ကုဋေ
-၁.၃၅ ကုဋေ
Net interest expenses
-၁.၀၉ ကုဋေ
-၁.၀၇ ကုဋေ
-၁.၀၄ ကုဋေ
-၁.၁၇ ကုဋေ
Depreciation and amortization charges
-
-
-
-
EBITDA
-၃.၀၆ ကုဋေ
-၁.၆၀ ကုဋေ
-၂.၅၁ ကုဋေ
-၂.၂၆ ကုဋေ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ